Abstract:Graphical and Lay Summary L‐asparaginases (EC 3.5.1.1) catalyze the conversion of L‐asparagine to L‐aspartic acid and ammonia. Although bacterial L‐asparaginases are commonly used in leukemia treatment, their immunogenicity has necessitated the exploration of alternative sources. Yeast‐derived L‐asparaginases, such as Lachancea thermotolerans L‐asparaginase (LtASNase), present a potential strategy for reducing toxicity. In this study, the Lys99Ala mutant of LtASNase was generated through semi‐rational design, resulting in significantly enhanced activity. In vitro testing against leukemia cell lines demonstrated that the mutant enzyme exhibits antileukemic activity comparable to commercial bacterial enzymes. These findings highlight the potential of yeast‐derived L‐asparaginases for therapeutic development. L‐asparaginases (EC 3.5.1.1) are amidohydrolase enzymes that predominantly catalyze conversion of L‐asparagine to L‐aspartic acid and ammonia. In addition, some exhibit secondary L‐glutaminase activity. Escherichia coli and Erwinia chrysanthemi L‐asparaginases are widely used in the pharmaceutical industry to produce therapeutically important compounds. In the therapeutic use of enzymes, bacterial L‐asparaginases can trigger immune responses, leading to a high rate of adverse effects that diminish the effectiveness of the treatment. This situation has forced scientists to search for promising L‐asparaginases from new sources. Yeast L‐asparaginases could be useful in reducing toxicity and enhancing efficacy but they have been poorly studied to date. Here, we characterized the yeast Lachancea thermotolerans L‐asparaginase (LtASNase) purified by affinity chromatography. It has a specific activity of 313.8 U/mg and a high kcat value (312.4 s). We demonstrated through a semi‐rational design that the mutations of Lys99 show varying effects on catalytic activity, with the Lys99Ala mutant increasing specific activity 3.3‐fold. Furthermore, the in vitro antileukemic activity of the non‐formulated form of Lys99Ala LtASNase was evaluated against SUP‐B15 and REH cell lines. The results demonstrated that LtASNase exhibits significant antileukemic potential, comparable to commercial type II bacterial enzymes. The understanding of the mutant L‐asparaginases examined in this study will significantly contribute to the development of new and more effective yeast‐derived asparaginases.

Serum uric acid: Marker for atherosclerosis as it is positively associated with “atherogenic index of plasma”

A Structural In Silico Analysis of the Immunogenicity of L-Asparaginase from Penicillium cerradense

Isolation of asparaginase-producing microorganisms and evaluation of the enzymatic antitumor activity

Comparative studies on modeling and optimization of fermentation process conditions for fungal asparaginase production using artificial intelligence and machine learning techniques

A Novel Low Velocity Robotic Penetrator Based on Ampere Force

Production of highly cytotoxic and low immunogenic L-asparaginase from Stenotrophomonas maltophilia EMCC2297

In vitro and in silico analysis unravelled clinically desirable attributes of Bacillus altitudinis L-asparaginase

Substrate Affinity Is Not Crucial for Therapeutic L-Asparaginases: Antileukemic Activity of Novel Bacterial Enzymes

Production of a Novel Marine Pseudomonas aeruginosa Recombinant L-Asparaginase: Insight on the Structure and Biochemical Characterization

Semi-quantitative detection for L-asparaginase producing fungi and the impact of carbon and nitrogen sources on enzyme activity

L‐Asparaginase from Lachancea Thermotolerans: Effect of Lys99Ala on Enzyme Performance and in vitro Antileukemic Efficacy

Screening and Optimization of Process Parameters for the Production of l-asparaginase by Indigenous Fungal-Type Strains

Polymerization of ADP-Ribose Pyrophosphatase: conversion mechanism of Mg2+-dependent ADP-Ribose Pyrophosphatase into Mg2+-independent form

Expression and purification of L-asparaginase from Escherichia coli and the inhibitory effects of cyclic dipeptides

A Comprehensive Review of L-Asparaginase: Production, Applications and Therapeutic Potential in Cancer Treatment

Improving Toxicological, Immune and Inflammatory Responses

Insights into the Microbial L-Asparaginases: from Production to Practical Applications

Homology modeling and molecular docking studies to decrease glutamine affinity of Yarrowia lipolytica L-asparaginase

Thermostability Improvement of L-Asparaginase from Acinetobacter soli via Consensus-Designed Cysteine Residue Substitution

[Sacral cyst causing lumbago and lower extremity pain. 2. Intrasacral occult meningocele].

時間比例基週波形內差 – 一個國語音節信號合成之新方法 (Time-Proportionated Interpolation of Pitch Waveforms – A New Method for Mandarin Syllable-Signal Synthesis) [In Chinese]